Recent Analysis Shows FTD Companies, TG Therapeutics, National HealthCare, Lennox International, PRA Group, and Unit Market Influences — Renewed Outlook, Key Drivers of Growth

Recent Analysis Shows FTD Companies, TG Therapeutics, National HealthCare, Lennox International, PRA Group, and Unit Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FTD Companies, Inc. (NASDAQ:FTD), TG Therapeutics, Inc. (NASDAQ:TGTX), National HealthCare Corporation (NYSE:NHC), Lennox International, Inc. (NYSE:LII), PRA Group, Inc. (NASDAQ:PRAA), and Unit Corporation (NYSE:UNT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

FTD DOWNLOAD: http://Fundamental-Markets.com/register/?so=FTD
TGTX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TGTX
NHC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NHC
LII DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LII
PRAA DOWNLOAD:
http://Fundamental-Markets.com/register/?so=PRAA
UNT DOWNLOAD:
http://Fundamental-Markets.com/register/?so=UNT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine FTD Companies, Inc. (NASDAQ:FTD), TG Therapeutics, Inc. (NASDAQ:TGTX), National HealthCare Corporation (NYSE:NHC), Lennox International, Inc. (NYSE:LII), PRA Group, Inc. (NASDAQ:PRAA), and Unit Corporation (NYSE:UNT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

FTD COMPANIES, INC. (FTD) REPORT OVERVIEW

FTD Companies' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, FTD Companies reported revenue of $278.08MM vs $280.67MM (down 0.92%) and basic earnings per share -$5.58 vs -$3.14. For the twelve months ended December 31st, 2017 vs December 31st, 2016, FTD Companies reported revenue of $1,084.03MM vs $1,122.00MM (down 3.38%) and basic earnings per share -$8.52 vs -$3.03. FTD Companies is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast for the next fiscal year is $0.28 and is expected to report on April 1st, 2019.

To read the full FTD Companies, Inc. (FTD) report, download it here: http://Fundamental-Markets.com/register/?so=FTD

-----------------------------------------

TG THERAPEUTICS, INC. (TGTX) REPORT OVERVIEW

TG Therapeutics' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, TG Therapeutics reported revenue of $0.04MM vs $0.04MM (unchanged) and basic earnings per share -$0.46 vs -$0.49. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TG Therapeutics reported revenue of $0.15MM vs $0.15MM (unchanged) and basic earnings per share -$1.91 vs -$1.60. TG Therapeutics is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.52. The estimated EPS forecast for the next fiscal year is -$1.94 and is expected to report on March 14th, 2019.

To read the full TG Therapeutics, Inc. (TGTX) report, download it here: http://Fundamental-Markets.com/register/?so=TGTX

-----------------------------------------

NATIONAL HEALTHCARE CORPORATION (NHC) REPORT OVERVIEW

National HealthCare's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, National HealthCare reported revenue of $246.31MM vs $238.00MM (up 3.49%) and basic earnings per share $1.41 vs $0.91 (up 54.95%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, National HealthCare reported revenue of $967.00MM vs $926.64MM (up 4.36%) and basic earnings per share $3.70 vs $3.34 (up 10.78%). National HealthCare is expected to report earnings on May 9th, 2018. The report will be for the fiscal period ending March 31st, 2018.

To read the full National HealthCare Corporation (NHC) report, download it here: http://Fundamental-Markets.com/register/?so=NHC

-----------------------------------------

LENNOX INTERNATIONAL, INC. (LII) REPORT OVERVIEW

Lennox International's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Lennox International reported revenue of $834.80MM vs $793.40MM (up 5.22%) and basic earnings per share $0.91 vs $1.02 (down 10.78%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Lennox International reported revenue of $3,839.60MM vs $3,641.60MM (up 5.44%) and basic earnings per share $7.25 vs $6.39 (up 13.46%). Lennox International is expected to report earnings on July 23rd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $2.83. The estimated EPS forecast for the next fiscal year is $11.43 and is expected to report on February 5th, 2019.

To read the full Lennox International, Inc. (LII) report, download it here: http://Fundamental-Markets.com/register/?so=LII

-----------------------------------------

PRA GROUP, INC. (PRAA) REPORT OVERVIEW

PRA Group's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, PRA Group reported revenue of $205.67MM vs $155.26MM (up 32.47%) and basic earnings per share $1.92 vs -$0.38. For the twelve months ended December 31st, 2017 vs December 31st, 2016, PRA Group reported revenue of $813.57MM vs $830.58MM (down 2.05%) and basic earnings per share $3.55 vs $1.84 (up 92.93%). PRA Group is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $2.45 and is expected to report on February 26th, 2019.

To read the full PRA Group, Inc. (PRAA) report, download it here: http://Fundamental-Markets.com/register/?so=PRAA

-----------------------------------------

UNIT CORPORATION (UNT) REPORT OVERVIEW

Unit's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Unit reported revenue of $204.85MM vs $174.28MM (up 17.54%) and basic earnings per share $1.74 vs $0.04 (up 4,250.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Unit reported revenue of $739.64MM vs $602.18MM (up 22.83%) and basic earnings per share $2.31 vs -$2.71. Unit is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $0.99 and is expected to report on February 28th, 2019.

To read the full Unit Corporation (UNT) report, download it here: http://Fundamental-Markets.com/register/?so=UNT

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.